Northern Trust’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-168,040
| Closed | -$35.4K | – | 4555 |
|
|
2023
Q2 | $35.4K | Hold |
168,040
| – | – | ﹤0.01% | 4298 |
|
|
2023
Q1 | $26.9K | Sell |
168,040
-910
| -0.5% | -$404 | ﹤0.01% | 4394 |
|
|
2022
Q4 | $93.8K | Hold |
168,950
| – | – | ﹤0.01% | 4107 |
|
|
2022
Q3 | $201K | Buy |
168,950
+570
| +0.3% | +$615 | ﹤0.01% | 3872 |
|
|
2022
Q2 | $106K | Sell |
168,380
-609,805
| -78% | -$468K | ﹤0.01% | 4146 |
|
|
2022
Q1 | $887K | Sell |
778,185
-35,376
| -4% | -$42.3K | ﹤0.01% | 3473 |
|
|
2021
Q4 | $1.83M | Sell |
813,561
-119,976
| -13% | -$301K | ﹤0.01% | 3258 |
|
|
2021
Q3 | $3.19M | Sell |
933,537
-48,072
| -5% | -$148K | ﹤0.01% | 3023 |
|
|
2021
Q2 | $2.94M | Buy |
981,609
+769,207
| +362% | +$2.43M | ﹤0.01% | 3168 |
|
|
2021
Q1 | $686K | Buy |
212,402
+53,879
| +34% | +$180K | ﹤0.01% | 3728 |
|
|
2020
Q4 | $336K | Sell |
158,523
-7,839
| -5% | -$12.9K | ﹤0.01% | 3823 |
|
|
2020
Q3 | $195K | Sell |
166,362
-1,943
| -1% | -$2K | ﹤0.01% | 3827 |
|
|
2020
Q2 | $152K | Sell |
168,305
-5,598
| -3% | -$5.33K | ﹤0.01% | 3825 |
|
|
2020
Q1 | $146K | Sell |
173,903
-335
| -0.2% | -$388 | ﹤0.01% | 3751 |
|
|
2019
Q4 | $167K | Sell |
174,238
-1,198
| -0.7% | -$1.31K | ﹤0.01% | 3836 |
|
|
2019
Q3 | $181K | Sell |
175,436
-737
| -0.4% | -$1K | ﹤0.01% | 3788 |
|
|
2019
Q2 | $317K | Buy |
176,173
+6,326
| +4% | +$10.2K | ﹤0.01% | 3682 |
|
|
2019
Q1 | $320K | Sell |
169,847
-118
| -0.1% | -$173 | ﹤0.01% | 3662 |
|
|
2018
Q4 | $201K | Sell |
169,965
-4,092
| -2% | -$7.36K | ﹤0.01% | 3790 |
|
|
2018
Q3 | $472K | Sell |
174,057
-3,137
| -2% | -$6.49K | ﹤0.01% | 3642 |
|
|
2018
Q2 | $339K | Buy |
177,194
+9,204
| +5% | +$18.6K | ﹤0.01% | 3700 |
|
|
2018
Q1 | $353K | Buy |
167,990
+3,303
| +2% | +$7.08K | ﹤0.01% | 3657 |
|
|
2017
Q4 | $334K | Sell |
164,687
-214,756
| -57% | -$446K | ﹤0.01% | 3656 |
|
|
2017
Q3 | $505K | Buy |
379,443
+1,372
| +0.4% | +$1.7K | ﹤0.01% | 3570 |
|
|
2017
Q2 | $593K | Sell |
378,071
-381,838
| -50% | -$736K | ﹤0.01% | 3551 |
|
|
2017
Q1 | $2.45M | Sell |
759,909
-6,373
| -0.8% | -$15.7K | ﹤0.01% | 2980 |
|
|
2016
Q4 | $1.03M | Sell |
766,282
-4,350
| -0.6% | -$5.68K | ﹤0.01% | 3339 |
|
|
2016
Q3 | $1.2M | Buy |
770,632
+60,312
| +8% | +$92.7K | ﹤0.01% | 3287 |
|
|
2016
Q2 | $945K | Buy |
710,320
+109,845
| +18% | +$514K | ﹤0.01% | 3362 |
|
|
2016
Q1 | $3.17M | Buy |
600,475
+6,218
| +1% | +$38.1K | ﹤0.01% | 2708 |
|
|
2015
Q4 | $4.67M | Buy |
594,257
+15,213
| +3% | +$131K | ﹤0.01% | 2497 |
|
|
2015
Q3 | $4.89M | Buy |
579,044
+22,524
| +4% | +$208K | ﹤0.01% | 2460 |
|
|
2015
Q2 | $6.09M | Buy |
556,520
+16,327
| +3% | +$210K | ﹤0.01% | 2402 |
|
|
2015
Q1 | $7.55M | Buy |
540,193
+5,235
| +1% | +$80K | ﹤0.01% | 2236 |
|
|
2014
Q4 | $9.04M | Sell |
534,958
-6,523
| -1% | -$95K | ﹤0.01% | 2107 |
|
|
2014
Q3 | $7.27M | Sell |
541,481
-27,192
| -5% | -$324K | ﹤0.01% | 2257 |
|
|
2014
Q2 | $7.25M | Sell |
568,673
-40,144
| -7% | -$418K | ﹤0.01% | 2272 |
|
|
2014
Q1 | $7.24M | Sell |
608,817
-57,531
| -9% | -$772K | ﹤0.01% | 2329 |
|
|
2013
Q4 | $9.2M | Buy |
666,348
+14,063
| +2% | +$199K | ﹤0.01% | 2137 |
|
|
2013
Q3 | $11.4M | Buy |
652,285
+140,460
| +27% | +$2.69M | ﹤0.01% | 1935 |
|
|
2013
Q2 | $8.29M | Buy |
+511,825
| New | +$15.8M | ﹤0.01% | 2054 |
|
Other funds holding INFI
Northern Trust's INFI Position: Q3 2023 in Review
Northern Trust sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 168,040 shares — an estimated $35.4K sold.
Northern Trust first reported a position in INFI in Q2 2013 and held it in 41 quarters. The position peaked at $11.4M in Q3 2013. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.
- Northern Trust reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
- Northern Trust sold 168,040 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $35.4K.
- Northern Trust first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 41 quarters.
- Northern Trust's Infinity Pharmaceuticals, Inc. position peaked at $11.4M in Q3 2013.
- 3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.
Based on Northern Trust's 13F filing for Q3 2023, filed 13 Nov 2023.